CLINICAL_TRIALS
trial_result
· 2011-11-23
Clinical Trial Update: A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg [Phase 3]
Summary
A Phase 3 trial comparing valsartan 160 mg vs 320 mg for hypertension has completed. The trial was sponsored by Novartis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED